117 related articles for article (PubMed ID: 3436613)
1. Effects of progestogens on lipemia and lipolysis in rat: effects of progesterone, megestrol acetate, norethindrone acetate, and nomegestrol acetate.
Hazard MC; Clavet M; Chapignac A; Paris J
Fundam Clin Pharmacol; 1987; 1(4):233-42. PubMed ID: 3436613
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
3. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
Couzinet B; Young J; Brailly S; Chanson P; Thomas JL; Schaison G
J Clin Endocrinol Metab; 1996 Dec; 81(12):4218-23. PubMed ID: 8954018
[TBL] [Abstract][Full Text] [Related]
4. Effects of oestradiol valerate plus two different progestogens on serum lipids during post-menopausal replacement therapy.
Makkonen M; Saarikoski S; Penttilä I
Maturitas; 1991 Dec; 14(1):43-8. PubMed ID: 1791771
[TBL] [Abstract][Full Text] [Related]
5. Lipolytic activity of progesterone and synthetic progestins on rat parametrial adipocytes in vitro.
Dorai V; Hazard MC; Paris J; Delansorne R
J Pharmacol Exp Ther; 1991 Aug; 258(2):620-5. PubMed ID: 1865361
[TBL] [Abstract][Full Text] [Related]
6. [Effects of a 19-norprogesterone derivative, the fourth decade nomegestrol acetate, on lipids].
Pélissier C; Jamin C; Colau JC
Ann Endocrinol (Paris); 2003 Jun; 64(3):216-26. PubMed ID: 12910065
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic properties of nomegestrol acetate.
Duc I; Botella J; Bonnet P; Fraboul F; Delansorne R; Paris J
Arzneimittelforschung; 1995 Jan; 45(1):70-4. PubMed ID: 7893274
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Lamberts SW; Uitterlinden P; Bons EG; Verleun T
Cancer Res; 1985 Mar; 45(3):1015-9. PubMed ID: 2982481
[TBL] [Abstract][Full Text] [Related]
10. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
11. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
12. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Bain SD; Jensen E; Celino DL; Bailey MC; Lantry MM; Edwards MW
J Bone Miner Res; 1993 Feb; 8(2):219-30. PubMed ID: 8442440
[TBL] [Abstract][Full Text] [Related]
13. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
14. Augmentative and inhibitory effects of chronic steroid injections on LH release and their dependency on time.
Kuhl H; Baziad A; Taubert HD
Endocrinol Exp; 1982 Jun; 16(2):93-101. PubMed ID: 7049671
[TBL] [Abstract][Full Text] [Related]
15. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
Botella J; Paris J; Lahlou B
Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
[TBL] [Abstract][Full Text] [Related]
16. Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women.
Basdevant A; Pelissier C; Conard J; Degrelle H; Guyene TT; Thomas JL
Contraception; 1991 Dec; 44(6):599-605. PubMed ID: 1773617
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
Maturitas; 1982 Aug; 4(2):103-11. PubMed ID: 6811837
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of three low dose progestogens, chlormadinone acetate, megestrol acetate and norethisterone, as oral contraceptives.
Hawkins DF; Benster B
Br J Obstet Gynaecol; 1977 Sep; 84(9):708-13. PubMed ID: 71917
[TBL] [Abstract][Full Text] [Related]
19. Effects of synthetic progestational steroids on liver and serum lipids in rats.
Uchida K; Nomura Y; Kadowaki M; Takeuchi N
Endocrinol Jpn; 1976 Apr; 23(2):97-108. PubMed ID: 954685
[TBL] [Abstract][Full Text] [Related]
20. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Lamberts SW; van Koetsveld P; Verleun T
Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
